BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Healthtrust
Colorcon
Chubb
Cerilliant
AstraZeneca
Chinese Patent Office
Boehringer Ingelheim
Fuji
Deloitte

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077856

« Back to Dashboard

NDA 077856 describes CLONAZEPAM, which is a drug marketed by Barr, Par Pharm, Sun Pharm Inds Inc, Accord Hlthcare, Actavis Elizabeth, Apotex Inc, Mylan, Mylan Pharms Inc, Prinston Inc, Sandoz, Teva, and Watson Labs, and is included in fifteen NDAs. It is available from forty-seven suppliers. Additional details are available on the CLONAZEPAM profile page.

The generic ingredient in CLONAZEPAM is clonazepam. There are ten drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the clonazepam profile page.
Summary for 077856
Tradename:CLONAZEPAM
Applicant:Prinston Inc
Ingredient:clonazepam
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 077856
Ingredient-typeBenzodiazepines
Medical Subject Heading (MeSH) Categories for 077856
Suppliers and Packaging for NDA: 077856
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLONAZEPAM clonazepam TABLET;ORAL 077856 ANDA Qualitest Pharmaceuticals 0603-2948 0603-2948-13 15 TABLET in 1 BOTTLE, PLASTIC (0603-2948-13)
CLONAZEPAM clonazepam TABLET;ORAL 077856 ANDA Qualitest Pharmaceuticals 0603-2948 0603-2948-26 150 TABLET in 1 BOTTLE, PLASTIC (0603-2948-26)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Jun 28, 2006TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Jun 28, 2006TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Jun 28, 2006TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Accenture
Colorcon
QuintilesIMS
Daiichi Sankyo
Julphar
Mallinckrodt
US Department of Justice
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot